Altomari Alfred's Form 4 filing
Agile Therapeutics Inc (AGRX) · filed Oct 14, 2021
- Accession no.
- 0001104659-21-126012
- Filed
- Oct 14, 2021
- Trade date
- Oct 13, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altomari AlfredCIK 0001285644 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 | Common Stock | PPurchaseAcquired | +58,824 | –F1 | – | 573,734 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 | Common Stock | PPurchaseAcquired | +29,412 | –F1 | – | 29,412 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reporting person purchased the reported securities at a combined public offering price of $0.85 per one share of common stock together with one-half of a warrant to purchase one share of common stock.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.